| 229 - 239 |
Induction of an in vitro reversible hypometabolism through chitosan-based nanoparticles
Colonna C, Dorati R, Conti B, Modena T, Biggiogera M, Spedito A, Genta I |
| 240 - 247 |
In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles
Gaihre B, Lee YH, Khil MS, Yi HK, Kim HY |
| 248 - 257 |
Synthesis and characterization of new biopolymeric microcapsules containing DEHPA--TOPO extractants for separation of uranium from phosphoric acid solutions
Outokesh M, Tayyebi A, Khanchi A, Grayeli F, Bagheri G |
| 258 - 267 |
In vitro evaluation of the antioxidant activity of liposomal flavonols by the HRP--H2O2--luminol system
Landi-Librandi AP, de Oliveira CA, Azzolini AECS, Kabeya LM, Del Ciampo JO, Bentley MVLB, Lucisano-Valim YM |
| 268 - 279 |
Polyethyleneimine-modified pectin beads for colon-specific drug delivery: In vitro and in vivo implications
Das S, Chaudhury A, Ng KY |
| 280 - 285 |
Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate
Feng FF, Zheng DD, Zhang DR, Duan CX, Wang YC, Jia LJ, Wang FH, Liu Y, Gao Q, Zhang Q |
| 286 - 293 |
In vitro anticancer activity of doxorubicin-loaded gelatin-coated magnetic iron oxide nanoparticles
Gaihre B, Khil MS, Kim HY |
| 294 - 300 |
A novel microparticulate vaccine for melanoma cancer using transdermal delivery
Bhowmik T, D'Souza B, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza MJ |
| 301 - 310 |
Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis
Kunjachan S, Gupta S, Dwivedi AK, Dube A, Chourasia MK |
| 311 - 322 |
Effect of decisive formulation variables on bioencapsulation efficiency and integrity of yeast biocapsules for oral itraconazole delivery
Sangwai MB, Vavia PR |
| 323 - 335 |
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers
Grabnar PA, Kristl J |
